This inventor holds 28 USPTO granted patents and 23 published patent applications, plus 3 CIPO patents and 23 EPO patents, primarily in Gene Therapy. Top assignees: Genzyme Corporation, Ionis Pharmaceuticals, Inc., The Brigham and Women's Hospital, Inc.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brighton, MA (US) (2013 - 2022)
- Bridgewater, NJ (US) (2018 - 2022)
- West Newton, MA (US) (2016 - 2024)
Company Filing History:
15 out of 825 
7 out of 289 
4 out of 1,429 
Years Active: 2013-2025
Areas of Expertise:
Title: Innovations in Gene Therapy: The Work of Lamya S Shihabuddin
Introduction
Lamya S Shihabuddin is a prominent inventor based in West Newton, MA. With an impressive portfolio of 25 patents, he has made significant contributions to the fields of gene therapy and ocular disorders. His pioneering work is at the intersection of gene therapy and neuroscience, focusing on developing new methods and compositions for improving the treatment of various diseases.
Latest Patents
Among his latest patents are innovations involving adeno-associated virus (AAV) vectors for retinal and central nervous system (CNS) gene therapy. The improvements in the recombinant adeno-associated virus, such as rAAV2 and rAAVrh8R, include amino acid substitutions that enhance their interaction with heparan sulfate proteoglycan. These advances lead to improved transduction of retinal cells and more effective treatments for ocular diseases. Additionally, the patents outline methods for delivering these rAAVs to the CNS and treating related disorders, showcasing the potential for groundbreaking advancements in neurodegenerative therapies.
Career Highlights
Shihabuddin's career has seen him work with leading companies in the biotechnology sector. Notably, he has been associated with Genzyme Corporation and Ionis Pharmaceuticals, Inc., where he has leveraged his expertise to develop innovative therapeutic solutions. His work in these organizations has contributed to advancing research and applications in gene therapy.
Collaborations
Collaboration has been a key component of Shihabuddin's success. He has worked alongside talented colleagues such as Seng H Cheng and Marco A Passini, fostering an environment of shared knowledge and innovation. These collaborations have resulted in significant advancements in the methodologies he has pioneered in gene therapy.
Conclusion
Lamya S Shihabuddin is a visionary inventor whose work continues to push the boundaries of gene therapy. With 25 patents reflecting his ingenuity and dedication, he remains a pivotal figure in developing new treatments for complex disorders. His innovations promise to facilitate significant improvements in the care and outcomes for patients suffering from ocular and CNS conditions, solidifying his impact on the future of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile